Norway - Lipid Modifying Medicine Use
Since 2014, Norway Lipid Modifying Medicine Use was up 3.6% year on year. With 147.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 3 among other countries in Lipid Modifying Medicine Use. Norway is overtaken by United Kingdom, which was number 2 at 152.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Belgium at 145.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark topped the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is an increase of 3.5% compared to 2018. Lithuania recorded the best 5 years average growth at +18.8% per year, while Slovakia witnessed the worst performance at -8.7% per year.
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 147.60 |
| 2018 | 142.20 |
| 2017 | 135.60 |
| 2016 | 131.80 |
| 2015 | 128.60 |
How does Norway rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data |
| 3 |
#3
Norway
|
148 | 2019 | +3.8 % | +3.6 % | View data |
| 4 |
#4
Belgium
|
146 | 2019 | +2.6 % | +2.1 % | View data |
| 5 |
#5
Slovenia
|
142 | 2019 | +3.0 % | +4.8 % | View data |